Ciliatech Raises €3.5M in Series A Funding
Ciliatech notes the funds will advance the development of their disruptive glaucoma implant CID and initiate clinical trials in Europe, paving the way for CE mark approval.
- Go to the previous page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- …
- 17
- Go to the next page